New Haven, Conn.-based Yale New Haven Health named Thomas Jackiewicz CEO, effective Feb. 1, 2027, according to a Nov. 16 news release shared with Becker’s.
Mr. Jackiewicz is president of the University of Chicago Health System, which operates under the UChicago Medicine brand. He joined the system in 2020 as president of University of Chicago Medical Center and COO of the health system. During his tenure, operating revenue more than doubled and operating profit increased more than sixfold, and University of Chicago Medical Center’s Vizient ranking for access to care improved from 34th in 2020 to eighth in 2026, according to the release.
He previously served as CEO of Los Angeles-based Keck Medicine of USC from 2012 to 2020 and CEO of University of California San Diego Health System from 2009 to 2011.
“Throughout the search process, we were particularly impressed by his ability to understand the unique needs of an organization and its market and build a strategy around those needs, rather than rely on a single playbook,” Jack Callahan, chair of the Yale New Haven Health board of trustees, said in the release.
Mr. Jackiewicz, a Bridgeport, Conn., native, said in the release that he is honored to join the organization at an important point in its evolution.
He will succeed Pamela Sutton-Wallace, who has served as acting CEO since Christopher O’Connor stepped down in June after 14 years with the system. Mr. Callahan credited Ms. Sutton-Wallace with advancing quality and safety improvements, strengthening financial performance and preparing for the opening of the Adams Neurosciences Center.
Yale New Haven Health reported operating income of $33 million through the third quarter of 2026, up from an operating loss of $40.2 million a year earlier. The system posted a $197 million operating loss in fiscal 2025. Yale New Haven Health has five hospitals and is affiliated with Yale University and Yale Medicine.